/ Education / Postgraduate Courses

Msc in Molecular and Translational Neuroscience

Course Coordinator

Profa. Doutora Ana Cristina Carvalho Rego

Email: arego@fmed.uc.pt

Duration 4 Semestres

Nº Vagas

20

ECTS

120

Anual fee

1.500,00€ (7.000,00€ estudante internacional)

Língua de Aprendizagem / Avaliação

Inglês

Contacts

Gestão Académica | Estudos Pós-Graduados da FMUC

Telefone: + 351 239 857 720

e-mail: posgraduado@fmed.uc.pt

Gabinete de Estudos Avançados

Telefone: +351 239 857 729

e-mail: gea@fmed.uc.pt

More information:

https://apps.uc.pt/courses/en/course/8261/2019-2020

Study Programme

The work developed by a student during one academic year, according to the indicative plan of the course and on a full time basis, totals 60 ECTS.

General Objectives of the Course
The aim of the Master degree in Molecular and Translational Neuroscience is to offer advanced training in the field of Neurosciences in the area of fundamental or basic (molecular and cellular) neurosciences, addressing the different aspects of neurobiology, neuroanatomy, neurophysiology and neuropsychology, and to promote a strong interaction with clinical neurosciences through the integration of the study of the nervous system in pathological conditions, deepening the translational analysis of the different diseases of the nervous system and the application of novel methodologies and therapies.
Specific objectives:
1. To deepen the fundamental aspects of the study in the area of Neurosciences;
2. To integrate the clinical and translational aspects associated with different pathologies of the nervous system;
3. To evaluate the methods and techniques used for the study of the nervous system and the effectiveness of the application of pharmacological, cellular and molecular/genetic therapies; and
4. To consolidate the knowledge in Neurosciences through the development of an original research project leading to the Master's thesis.

Admission Requirements
Can apply for access to the cycle of studies leading to the master's degree in Molecular and Translational Neurosciences:
a) Holders of the undergraduate degree or legal equivalent in Medicine, Medical Dentistry, Veterinary Medicine, Biomedical Engineering, Pharmaceutical Sciences, Biomedical Sciences, Psychology, Biochemistry, Biology, Genetics, Nursing, Clinical Labwork and related areas, with minimum score of 14 (out of 20) or lower rating who demonstrate additional technical or research experience, or holders of master degree with lower grading after curricular evaluation by the Scientific Committee.
b) Holders of a foreign higher academic degree granted following a 1st cycle of studies organised in accordance with the principles of the Bologna Process by a country adhering to this Process, in the areas referred to in a);
c) Holders of a higher academic degree obtained abroad that is recognized as satisfying the objectives of the undergraduate degree in one of the areas mentioned in the previous paragraphs by the Scientific Council of the Faculty of Medicine of the University of Coimbra (FMUC); and
d) In duly justified cases, the holders of a school, scientific or professional curriculum, which is recognized as attesting to the ability to carry out this cycle of studies by the Scientific Council of FMUC.

Learning Objectives and Intended Skills
At the end of the Master degree in Molecular and Translational Neurosciences, the new master should acquire general competences in terms of knowledge, skills and attitudes, which are prerequisites for applying for more advanced training programs within the framework of the 3rd cycle, which includes the PhD program in Health Sciences, coordinated by the Faculty of Medicine of the University of Coimbra, or PhD programs in Neuroscience. In particular, this masters degree will provide research-related competences on the understanding of scientific methodologies and results, and communication of interdisciplinary themes in Neurosciences. The masters student will be able to consolidate the basis of molecular and cellular neuroscience with the pathophysiological and symptomatic analysis of different diseases of the nervous system. It is also intended that the student demonstrates knowledge regarding the influence of selective compounds as therapeutic measures
of disorders of the nervous system and the development and potential use of novel (e.g. cellular and molecular/genetic) therapies. At this level of skills, the new master should be able to communicate with oral and written scientific language in English, accurately interpret the information obtained from medical and/or laboratory data in order to determine the neuropathological basis of diseases of the nervous system, demonstrate an open and critical view, know how to select the information contained in original scientific journals, based on the topic of interest, know how to present and interpret the results of research and/or obtained in clinical trials on new drugs and other quantitative or qualitative studies
described in the biomedical and scientific literature related to Neuroscience, be able to formulate simple questions related to research in Biomedicine and Neurosciences, and to design studies or experiments that allow answering these questions. This characteristic, together with the knowledge obtained in the theoretical and practical training of the 1st year, will allow the student to have a greater autonomy in the development of the project leading to the Master degree. In terms of attitudes, the new master should have personal values related to integrity, honesty, responsibility, punctuality, use of the most effective technical and scientific means of experimental evaluation that allow the development of the project leading to the Master degree, take initiative to continuous training, knowing how to identify strategies for achieving lifelong learning goals, how to
work together and cooperate with colleagues, accept and respect criticism, understand strengths and weaknesses, demonstrate self-reflection, and, in cases where translational or clinical work is developed, apply the principles of informed consent and take into account the aspects related to the application of ethics to (bio)medical research.

APPLICATIONS 2024/2025

1ª fase – Does not open applications

2ª fase – 3 de junho a 15 de julho de 2024

3ª fase – 2 a 13 de setembro de 2024

ON-LINE APPLICATIONS HTTPS://INFORESTUDANTE.UC.PT/NONIO/SECURITY/CANDIDATURAS.DO

https://www.uc.pt/en/applications/

Team

Ana Cristina Carvalho Rego, Ana Luísa Monteiro Carvalho, Ana Paula Pereira da Silva Martins, António Francisco Rosa Gomes Ambrósio, António João Ferreira de Macedo e Santos, Carlos Alberto Fontes Ribeiro, Carlos Jorge Alves Miranda Bandeira Duarte, Catarina Alexandra dos Reis Vale Gome, Cláudia Margarida Gonçalves Cavadas, Cláudia Maria Fragão Pereira, Emília da Conceição Pedrosa Duarte, Maria Filomena Rabaça Roque Botelho, Frederico Guilherme Sousa Costa Pereira, Guiomar Gonçalves Oliveira, Inês Esteves Baldeira, João Manuel da Fonseca Gomes de Lemos, Joaquim Carlos Neto Murta, Jorge Manuel Castelo Branco de Albuquerque Almeida, José Augusto Simões Goncalves Leitão, Luís Pereira de Almeida, Maria Manuela Monteiro Grazina, Marcelino Arménio Martins Pereira, Maria Cristina Januário Santos, Maria Isabel Jacinto Santana, Maria Manuela Pereira Vilar, Maria Salomé Ferreira Estima de Pinho, Mário Manuel Rodrigues Simões, Miguel Sá Sousa Castelo-Branco, Otília da Anunciação Cardoso d' Almeid, Paula Maria Garcia Agostinho, Paulo Fernando Martins Santos, Rodrigo Pinto dos Santos Antunes da Cunha, Rosa Cristina Simões Fernandes, Rufino Martins da Silva, Rui Manuel Dias Cortesão dos Santos Bernardes, Sandra Isabel Morais de Almeida Costa Cardoso, Sónia Raquel Marques Batista

Local

Subunidade 3 do Pólo III, Faculdade de Medicina da Universidade de Coimbra, Monday to Friday, face-to-face and daytime